Innovita Biological Technology Co., Ltd. (SHA:688253)
31.78
+1.03 (3.35%)
At close: Oct 31, 2025
Innovita Biological Technology Company Description
Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, focuses on the research and development, production and sales of POCT rapid diagnostic products.
The company offers pathogen detection and joint detection of multiple pathogen; gastrointestinal virus testing; respiratory tract infections solutions; pregnancy test; hepatitis virus testing; and eugenics testing.
The company was founded in 2006 and is based in Beijing, China.
Innovita Biological Technology Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 547 |
| CEO | Xiujie Zhang |
Contact Details
Address: Building 6, Yard 1 Beijing, 100070 China | |
| Phone | 86 10 8368 2249 |
| Website | innovita.com.cn |
Stock Details
| Ticker Symbol | 688253 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005Q14 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Xiujie Zhang | GM and Director |
| Xiujuan Zhao | Financial Director and Director |
| Xiaogang Zhang | Deputy GM and Director |
| Fukang Chen | Board Secretary |
| Ying Zhao | Accounting Supervisor |